Sigmoid E max Modeling To Define the Fixed Concentration of Enmetazobactam for MIC Testing in Combination with Cefepime
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sigmoid
E
max
Modeling To Define the Fixed Concentration of Enmetazobactam for MIC Testing in Combination with Cefepime
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 65, Issue 8, Pages -
Publisher
American Society for Microbiology
Online
2021-06-14
DOI
10.1128/aac.00926-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Third-generation cephalosporin resistance in clinical isolates of Enterobacterales collected between 2016–2018 from USA and Europe: genotypic analysis of β-lactamases and comparative in vitro activity of cefepime/enmetazobactam
- (2021) Adam Belley et al. Journal of Global Antimicrobial Resistance
- In vitro efficacy of Imipenem-Relebactam and Cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae
- (2020) L. Tselepis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model
- (2020) Fabian Bernhard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae
- (2020) Adam Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017
- (2020) John A. Jernigan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to Novel β-Lactam–β-Lactamase Inhibitor Combinations
- (2020) Krisztina M. Papp-Wallace et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Interplay between β-lactamases and new β-lactamase inhibitors
- (2019) Karen Bush et al. NATURE REVIEWS MICROBIOLOGY
- Beyond piperacillin-tazobactam: cefepime and AAI101 as a potent β-lactam-β-lactamase inhibitor combination
- (2019) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Generating robust and informative nonclinical in vitro and in vivo bacterial infection model efficacy data to support translation to humans
- (2019) Jürgen B. Bulitta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents
- (2019) M.L. Rizk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of cefepime-enmetazobactam against Gram-negative isolates collected from United States and European hospitals during 2014-2015
- (2019) Ian Morrissey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam
- (2019) Adam Belley et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections
- (2019) Krisztina M. Papp-Wallace EXPERT OPINION ON PHARMACOTHERAPY
- Selecting the dosage of ceftazidime–avibactam in the perfect storm of nosocomial pneumonia
- (2019) Shampa Das et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A Systematic Approach to the Selection of the Appropriate Avibactam Concentration for Use with Ceftazidime in Broth Microdilution Susceptibility Testing
- (2018) Patricia A. Bradford et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamic modelling of β-lactam/β-lactamase inhibitor checkerboard data: illustration with aztreonam–avibactam
- (2018) A. Chauzy et al. CLINICAL MICROBIOLOGY AND INFECTION
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
- (2018) Alessandro Cassini et al. LANCET INFECTIOUS DISEASES
- Sparing carbapenem usage
- (2017) A. Peter R. Wilson JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of Ceftolozane Combined with Tazobactam againstEnterobacteriaceaein a Neutropenic Mouse Thigh Model.
- (2016) M. J. Melchers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in anIn VitroInfection Model
- (2013) Brian VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nonlinear least-squares data fitting in Excel spreadsheets
- (2010) Gerdi Kemmer et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started